|
LIMN Liminatus Pharma Inc 1971387 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-1,407,259.00 |
| Balance Sheet |
|
Current Assets
|
$3,392,467.00 |
|
Assets
|
$3,403,702.00 |
|
Current Liabilities
|
$3,040,423.00 |
|
Liabilities
|
$3,103,090.00 |
|
Equity
|
$300,612.00 |
|
Shares Out
|
55971633.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,985,288.00 |
|
Investing Cash Flow
|
$-788,108.00 |
| Market Analysis |
Market Cap
|
$6,156,879.63 |
|
Price
|
$0.11 |
|
BVPS
|
0.01 |
|
PB
|
11.00 |
|
EPS
|
-0.03 |
|
FCF
|
$-2,998,396.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:03 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:53 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LIMN documents filed with the SEC.
LIMN Filings
Clear
